Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
You're the flight surgeon: multiple sclerosis.
Role of myelin sheath energy metabolism in neurodegenerative diseases.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Midkine and multiple sclerosis.
Demyelination preceding a diagnosis of central nervous system lymphoma.
Neuro-Endocrine Networks Controlling Immune System in Health and Disease.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36.
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Estimating the marginal effect of socioeconomic factors on the demand of specialty drugs.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Fingolimod therapy for multiple sclerosis.
The treatment of neuromyelitis optica.
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
Association between Smoking and Health Outcomes in Postmenopausal Women Living with Multiple Sclerosis.
The role of antiproliferative gene Tob1 in the immune system.
Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.
Pages
« first
‹ previous
…
482
483
484
485
486
487
488
489
490
…
next ›
last »